A Study of Chinese Congenital Bicuspid Aortic Valve

Recruiting now

Conditions studied: Bicuspid Aortic Valve (BAV)

In brief

Pervious studies indicated that the prevalence of bicuspid aortic valve（BAV） might be higher in China. There is a familial predisposition to the development of BAV. The study analyzed epidemiological data on selected BAV and established a BAV cohort to observe disease progression and treatment outcomes.

Key facts

Study ID

NCT06802016

Run by

Ruijin Hospital

People needed

500

Starts

2025-01-18

Expected to finish

2035-12-31

Last updated by the study team

2025-02-03

Who can join

Age: 14 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The patients were aged 14-60 years;
• Definitive diagnosis of BAV by imaging (echocardiography, aortic CTA, cardiac magnetic resonance, etc.)
• Patients were informed about the nature of the study and agreed to participate in all the terms of the study and signed an informed consent form approved by the ethics committee.

You may not qualify if…

• Poor patient compliance and inability to complete follow-up visits as required;
• Rheumatic heart valve disease, other organic valve disease.
• Hyperthyroidism, severe anemia, and other factors that significantly affect hemodynamics.
• Other circumstances that the researcher believes should be excluded.

Where it is running

• Ruijin hospital, Shanghai JiaoTong University School of Medicine — Shanghai, Shanghai Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.